Zika virus circumvents host innate immunity by targeting the adaptor proteins MAVS and MITA

Area of Science:

• Virology
• Immunology
• Molecular Biology

Background:

• Zika virus (ZIKV) poses a significant neurotoxic threat with no current vaccines or treatments.
• Understanding ZIKV pathogenesis is critical for developing effective countermeasures.
• ZIKV is known to evade host antiviral responses.

Purpose of the Study:

• To elucidate the molecular mechanisms by which ZIKV circumvents host innate immunity.
• To identify specific ZIKV proteins involved in subverting antiviral signaling pathways.
• To reveal novel targets for therapeutic intervention against ZIKV infection.

Main Methods:

• Investigated the interaction of ZIKV proteins (NS3, NS2B3) with host antiviral factors (MAVS, MITA).
• Assessed the impact of ZIKV proteins on type I Interferon (IFN) production and IFN-stimulated genes.
• Analyzed the ubiquitination status and degradation of MAVS and MITA in ZIKV-infected cells.
• Examined the effect of ZIKV NS2B3 on polyinosinic:polycytidylic acid-triggered signaling.

Main Results:

• ZIKV strain SZ-WIV01 down-regulates type I IFN production and expression of IFN-stimulated genes.
• ZIKV nonstructural proteins NS3 and NS2B3 target MAVS and MITA, respectively, inhibiting the RIG-I-like receptor signaling pathway.
• NS3 interacts with MAVS, and NS2B3 interacts with MITA, leading to K48-linked polyubiquitination and degradation of these adaptor proteins.
• NS2B3 impairs K63-linked polyubiquitination of MITA, disrupting downstream sensor activation.

Conclusions:

• ZIKV NS3 and NS2B3 proteins are key effectors in ZIKV's immune evasion strategy.
• Targeting MAVS and MITA degradation is a novel mechanism employed by ZIKV to suppress innate immunity.
• This study provides critical insights into ZIKV pathogenesis, identifying potential targets for vaccine and drug development.